Susquehanna International Group
ALIM

Susquehanna International Group’s Alimera Sciences ALIM Stock Holding History

Susquehanna International Group’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-707
Closed -$14K – 10047
2017
Q3 		$14K Buy
+707
New +$15.1K ﹤0.01% 8673
2016
Q1 		– Sell
-3,093
Closed -$112K – 9812
2015
Q4 		$112K Buy
3,093
+1,213
+65% +$52.6K ﹤0.01% 8826
2015
Q3 		$62K Buy
1,880
+440
+31% +$24.8K ﹤0.01% 9319
2015
Q2 		$100K Buy
+1,440
New +$99.3K ﹤0.01% 9669
2014
Q4 		– Sell
-15,507
Closed -$1.26M – 10196
2014
Q3 		$1.26M Buy
15,507
+3,654
+31% +$312K ﹤0.01% 5477
2014
Q2 		$1.06M Buy
11,853
+4,980
+72% +$442K ﹤0.01% 5928
2014
Q1 		$813K Buy
6,873
+5,360
+354% +$521K ﹤0.01% 5878
2013
Q4 		$107K Buy
+1,513
New +$61.7K ﹤0.01% 8612

Susquehanna International Group's ALIM Position: Q2 2024 in Review

Susquehanna International Group sold out of Alimera Sciences (ALIM) in Q2 2024, closing a stake of 107,101 shares — an estimated $380K sold.

Susquehanna International Group first reported a position in ALIM in Q4 2013 and held it in 17 quarters. The position peaked at $979K in Q3 2014. 52 funds tracked by Wall St. Rank hold ALIM as of Q2 2024.

  • Susquehanna International Group reported no remaining Alimera Sciences position as of Q2 2024 after selling out during the quarter.
  • Susquehanna International Group sold 107,101 Alimera Sciences shares in Q2 2024, an estimated $380K.
  • Susquehanna International Group first reported a position in Alimera Sciences in Q4 2013 and held it in 17 quarters.
  • Susquehanna International Group's Alimera Sciences position peaked at $979K in Q3 2014.
  • 52 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.